
Quick Breakdown
CBD strain created by crossing Warlock with Cannatonic. Lab-tested with high CBD content. Limited edition release for medical use.
Characteristics
| Stock Availability | |
|---|---|
| Seed Type | |
| Flowering Period Type | |
| Indica / Sativa | |
| Strain Type | Asia-Central, Central America and Caribbean, Hybrid, Medicinal Strains, South American |
| Cannabinoid Profile | |
| Strength | |
| Environment | |
| Indoor Flowering Time | |
| Yield | |
| Smell / Taste | |
| Medical Strains | Epilepsy Relief, General Pain Relief, Glaucoma Relief, Inflammation Relief, Nerve Pain |
| Available as Single Seed |
Description
Overview of CBD-enriched Warlock
The Warlock strain, known for its flavor, was crossed with Cannatonic (high CBD-content) in collaboration with House of the Great Gardener from Canada. This new cross was tested in Canada, revealing a 2:1 THC:CBD ratio in 9 out of 24 samples, averaging 8% THC and 4% CBD. The top performers reached up to 16.86% THC and 15.58% CBD. This strain is part of the SERIOUSLY LIMITED edition line due to its distinctive CBD profile, with 15 out of 24 samples exceeding 4% CBD.
Developed in response to demand from Vancouver Island Compassion Society patients for a version of Warlock with high CBD and the same appealing aroma but with reduced psychoactive effects. This makes it an ideal choice for producing medical extracts, lotions, creams, and edibles. It’s specifically effective for treating Chronic Pain, Multiple Sclerosis, Epilepsy, Tourette Syndrome, Glaucoma, Arthritis, and more due to its CBD enrichment.
Customer Reviews
You must be logged in to post a review.
From £8.39






Reviews
There are no reviews yet.